Bioventus (BVS) Capital Expenditures (QoQ) (2020 - 2026)
Bioventus (BVS) Capital Expenditures (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.30 Bn | 175.00 Bn | 6.27 Bn |
| 2 | Stryker | 128.77 Bn | 125.89 Bn | 3.81 Bn |
| 3 | Medtronic | 107.99 Bn | 98.77 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.85 Bn | 66.39 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.12 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.98 Bn | 25.70 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.78 Bn | 20.65 Bn | 2.07 Bn |
| 10 | Bioventus | 831.78 Mn | 795.94 Mn | 90.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -7.93% |
| Dec 31, 2025 | -67.53% |
| Sep 27, 2025 | 383.49% |
| Jun 28, 2025 | -176.27% |
| Mar 29, 2025 | -7.50% |
| Dec 31, 2024 | 1,070.65% |
| Sep 28, 2024 | -6.98% |
| Jun 29, 2024 | -129.55% |
| Mar 30, 2024 | 4,057.14% |
| Dec 31, 2023 | -97.92% |
| Sep 30, 2023 | 112.96% |
| Jul 1, 2023 | -172.81% |
| Apr 1, 2023 | 157.23% |
| Dec 31, 2022 | -477.20% |
| Oct 1, 2022 | -66.44% |
| Jul 2, 2022 | 6,365.79% |
| Apr 2, 2022 | -99.15% |
| Dec 31, 2021 | 131.14% |
| Oct 2, 2021 | 619.89% |
| Jul 3, 2021 | 242.68% |